Overview
RGEN market data
Price History
RGEN price chart · 1M
- O
- 179.77
- H
- 183.01
- L
- 179.47
- C
- 180.23
- Vol
- 41,205.00
- Source
- US equities market feed
- Observed
- Aug 26, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $179.77
- Previous Close
- $181.66
- Day High
- $183.01
- Day Low
- $179.47
- 52 Week High
- $188.55
- 52 Week Low
- $101.00
- 7 Day Return
- +2.19%
- 30 Day Return
- +37.74%
- 90 Day Return
- +46.72%
- 1 Year Return
- +50.20%
- Daily Notional Volume
- $7.4M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 227.02 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.86 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.10 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 5.3% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $100.99 – $188.73 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $9.4B · P/B 4.38 · P/S 12.01.
Company News
Wells Fargo Maintains Overweight on Repligen, Raises Price Target to $185Benzinga · Jul 30, 2026, 2:17 PM
JP Morgan Maintains Overweight on Repligen, Raises Price Target to $175Benzinga · Jul 29, 2026, 6:36 PM
Nasdaq 100 Enters Correction, SanDisk Sinks Over 50% From Peak: Stock Market TodayBenzinga · Jul 28, 2026, 5:21 PM
12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga · Jul 28, 2026, 5:06 PM
Repligen shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance.Benzinga · Jul 28, 2026, 2:18 PM
Sherwin-Williams Posts Upbeat Q2 Earnings, Joins Itron, Armstrong World And Other Big Stocks Moving Higher On TuesdayBenzinga · Jul 28, 2026, 2:05 PM
8-K filing — REPLIGEN CORP (RGEN)SEC EDGAR · Jul 28, 2026, 11:13 AM
Repligen Q2 Adj. EPS $0.54 Beats $0.45 Estimate, Sales $204.128M Beat $201.483M EstimateBenzinga · Jul 28, 2026, 11:02 AM
Repligen Raises FY2026 Adj EPS Guidance from $1.97-$2.05 to $2.03-$2.09 vs $2.00 Est; Raises FY2026 Sales Guidance from $803.000M-$833.000M to $813.000M-$835.000M vs $822.537M EstBenzinga · Jul 28, 2026, 11:01 AM
Repligen Strengthens Cell Therapy Portfolio With BioLife AcquisitionBenzinga · Jul 22, 2026, 1:42 PM